Skip to main content
Log in

A New Soluble Gelatin Sponge for Transcatheter Hepatic Arterial Embolization

  • Laboratory Investigation
  • Published:
CardioVascular and Interventional Radiology Aims and scope Submit manuscript

Abstract

To prepare a soluble gelatin sponge (GS) and to explore the GS particles (GSPs) that inhibit development of collateral pathways when transcatheter hepatic arterial embolization is performed. The approval of the Institutional Committee on Research Animal Care of our institution was obtained. By means of 50 and 100 kDa of regenerative medicine–gelatin (RM-G), RM-G sponges were prepared by freeze-drying and heating to temperatures of 110–150°C for cross-linkage. The soluble times of RM-GSPs were measured in vitro. Eight swine for transcatheter hepatic arterial embolization were assigned into two groups: six received 135°C/50RM-GSPs, 125°C/100RM-GSPs, and 138°C/50RM-GSPs, with soluble time of 48 h or more in vitro; two swine received Gelpart GSPs (G-GSPs) with insoluble time of 14 days as a control. Transarterial chemoembolization was performed on two branches of the hepatic artery per swine. RM-GSPs heated at temperatures of 110–138°C were soluble. Mean soluble times of the RM-GSPs increased with higher temperature. Hepatic branches embolized with G-GSP remained occluded after 6 days, and development of collateral pathways was observed after 3 days. Hepatic branches embolized with 135°C/50RM-GSP and 125°C/100RM-GSP remained occluded for 4 h, and recanalization was observed after 1 day. Hepatic branches embolized with 138°C/50RM-GS remained occluded for 1 day, and recanalization was observed after 2 days with no development of collateral pathways. In RM-GSs with various soluble times that were prepared by modulating the heating temperature, 138°C/50RM-GSP was the soluble GSP with the longest occlusion time without inducing development of collateral pathways.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Doyon D, Mouzon A, Jourde AM et al (1974) L’embolisation arterielle hepatique dans les tumoeurs malignes du foie. Ann Radiol 17:593–603

    CAS  PubMed  Google Scholar 

  2. Goldstein HM, Wallace S, Anderson JH et al (1976) Transcatheter occlusion of abdominal tumors. Radiology 120:539–545

    CAS  PubMed  Google Scholar 

  3. Yamada R, Sato M, Kawabata M et al (1983) Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology 148:397–401

    CAS  PubMed  Google Scholar 

  4. Katsumori T, Kasahara T (2006) The size of gelatin sponge particles: differences with preparation method. Cardiovasc Intervent Radiol 29:1077–1083

    Article  PubMed  Google Scholar 

  5. Kim HC, Chung JW, Hong S et al (2007) Hepatocellular carcinoma with internal mammary artery supply: feasibility and efficacy of transcatheter chemoembolization and factors affecting patient prognosis. J Vasc Interv Radiol 16:611–620

    Article  Google Scholar 

  6. Nakai M, Sato M, Kawai N et al (2001) Hepatocellular carcinoma: involvement of the internal mammary artery. Radiology 219:147–152

    Google Scholar 

  7. Tanabe N, Iwasaki T, Chida N et al (1998) Hepatocellular carcinoma supplied by inferior phrenic arteries. Acta Radiol 39:443–447

    CAS  PubMed  Google Scholar 

  8. Kim HC, Chung W, Lee W et al (2005) Recognizing extrahepatic collateral vessels that supply hepatocellular carcinoma to avoid complications of transcatheter arterial chemoembolization. RadioGraphics 25:25–39

    Article  Google Scholar 

  9. Charnsangavei C, Chuang VP, Wallace S et al (1982) Angiographic classification of hepatic arterial collaterals. Radiology 144:485–494

    Google Scholar 

  10. Soo CS, Chuang VP, Wallace S et al (1983) Treatment of hepatic neoplasm through extrahepatic collaterals. Radiology 147:45–49

    CAS  PubMed  Google Scholar 

  11. Chung JW, Kim HC, Yoon JH et al (2006) Transcatheter arterial chemoembolization of hepatocellular carcinoma: prevalence and causative factors of extrahepatic collateral arteries in 479 patients. Korean J Rasiol 7:257–266

    Article  Google Scholar 

  12. Sato M, Yamada R (1983) Experimental and clinical studies on the hepatic artery embolization for treatment of hepatoma. Nippon Acta Radiologica 43:977–1005

    Google Scholar 

  13. Kanayama Y, Aoki C, Sakai Y (2007) Development of low endotoxin gelatin for regenerative medicine. Biol Pharm Bull 30:237–241

    Article  CAS  PubMed  Google Scholar 

  14. Tanaka K, Sato M, Terada M et al (1988) Echogenic spots early after hepatic arterial embolization. Jpn J Med Ultrasonics 15:397–403

    CAS  Google Scholar 

  15. Segall H (1923) An experimental anatomical investigation of blood and bile channels of the liver. Surg Gynecol Obstet 37:152–178

    Google Scholar 

  16. Healey JE Jr, Schroy PC, Sorensen RJ (1953) The intrahepatic distribution of the hepatic artery in man. J Int Coll Surg 20:133–148

    PubMed  Google Scholar 

  17. Hayashi K, Ina H, Tezuka M et al (2007) Local therapeutic results of computed tomography–guided transcatheter arterial chemoembolization for hepatocellular carcinoma: results of 265 tumors in 79 patients. Cardiovasc Intervent Radiol 30:1144–1155

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

No financial disclosures exist.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Morio Sato.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Takasaka, I., Kawai, N., Sato, M. et al. A New Soluble Gelatin Sponge for Transcatheter Hepatic Arterial Embolization. Cardiovasc Intervent Radiol 33, 1198–1204 (2010). https://doi.org/10.1007/s00270-010-9866-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00270-010-9866-2

Keywords

Navigation